BRCA1 and neoplasm: A subset of tumor tissues from 59 patients, were sequenced with a tissue panel, and no additional somatic BRCA1/2 mutations were identified, supporting the primary somatic BRCA1/2 analysis with Guardant360 on ctDNA.